BR2 Research Reactor Will Run With LEU In 2026 SCK CEN (ENS Corporate Member) announced that the BR2 research reactor will switch to low-enriched uranium (LEU) in 2026. Then BR2 will be the world’s first research reactor with high-performance fuel on low enriched uranium. As SCK CEN said, the change to LEU will help to…
Support For Nuclear Power Is Increasing Across Europe Recent opinion polls in several European countries showed widespread, increasing support for nuclear energy, considered an effective and crucial tool to mitigate climate change, boost decarbonisation, and secure national energy independence. Sweden The share of people who want to keep using nuclear power in Sweden is…
“Nuclear medicine has a great unexplored potential” Interview with Anthony Waked, PhD Fellow at SCK CEN – Belgian Nuclear Research Centre and the University of Liège, Belgium In the past decade, research has made tremendous progress and medical isotopes are expected to become a vital tool in the treatment of many types of cancers in…
Belgium Approves The Surface Radwaste Storage Facility In Dessel The Royal Decree published in the Belgian Official Gazette on 16 May 2023 issued the necessary authorisation for the construction and operation of the surface disposal facility in Dessel (Belgium). There the ONDRAF/NIRAS, the Belgian National Agency for Radioactive Waste and Enriched Fissile Material, will safely…
SCK CEN Announced A New Partnership To Accelerate The Fight Against Cancer The Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member) announced that the US-based SpectronRx will open its first European radiolabeling facility for sorely needed medical radioisotopes. The facility will be established on the premises of the research centre in Mol, Belgium. Both…
SCK CEN And TerThera Collaborate To Secure Terbium-161 Supply SCK CEN (ENS Corporate Member) and TerThera signed an agreement to handle together the production process of Terbium-161, a promising novel radionuclide for cancer treatment. Terbium-161 can meet the growing demand in cancer healthcare, exhibiting comparable (radio)chemical characteristics to known radiolanthanides. Targeted cancer therapies with Terbium-161 are expected…
Belgium Confirms The Extension Of NPPs Operations By 10 Years On 29th June 2023, ENGIE (ENS Corporate Member) and the Belgian Government signed an agreement specifying the terms of the extension of the nuclear reactors Doel-4 and Tihange-3. This agreement incorporates the non-binding agreement in principle signed on 9th January 2023 and specifies the following…
IAEA Positively Concluded Two Missions To Croatia And Belgium During the last month, the International Atomic Energy Agency (IAEA) successfully concluded two more missions to Europe. Delegations to Croatia and Belgium, made by international, independent experts and IAEA staff, provided advice and reviews on different aspects linked to nuclear and radiation safety, and radioactive waste management in…
IAEA Positively Concluded An ARTEMIS Mission to Belgium In mid-December, an Integrated Review Service for Radioactive Waste and Spent Fuel Management, Decommissioning and Remediation (ARTEMIS) review team concluded a ten-day mission to Belgium. The review was carried out at the request of the country and hosted by ONDRAF/NIRAS, the Belgian National Agency for Radioactive Waste and Enriched…
Tractebel To Support PanTera’s Radioisotope Production Facility Tractebel (ENS Corporate Member), together with its partner MODULO architects, will support the design and construction of PanTera’s actinium-225 production facility in Belgium, enabling breakthrough cancer treatments. The PanTera facility will be built in Mol (Belgium) and is dedicated to the production of 225Ac via photonuclear activation on…